A Study of Docetaxel for Injection (Albumin-bound) in Combination With Bevacizumab in Patients With Ovarian Cancer

NCT05325229 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Platinum-resistant Recurrent Ovarian Cancer

Interventions

DRUG: Docetaxel for injection (Albumin-bound)
DRUG: Bevacizumab

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.